CD8A and neoplasm: Our data also revealed that Phyduxon eliminated tumors and processed tumor antigens, triggering the expansion of downstream 4-1BB+IFN-γ+ CD8 T cells (Fig. 3); this indicates the emergence of tumor-specific CD8 T cells [36, 37].